Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

[1]  A. Cooke,et al.  The involvement of Ly2+ T cells in beta cell destruction. , 1990, Journal of autoimmunity.

[2]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[3]  L. Harrison,et al.  MHC Molecules and β-Cell Destruction: Immune and Nonimmune Mechanisms , 1989, Diabetes.

[4]  R. North,et al.  Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells , 1989, The Journal of experimental medicine.

[5]  G. Milon,et al.  Antibody to the murine type 3 complement receptor inhibits T lymphocyte- dependent recruitment of myelomonocytic cells in vivo , 1989, The Journal of experimental medicine.

[6]  Th. Mandel,et al.  Progression From Insulitis to β-Cell Destruction in NOD Mouse Requires L3T4+ T-Lymphocytes , 1988, Diabetes.

[7]  B. Charlton,et al.  Administration of Silica Particles or Anti-Lyt2 Antibody Prevents β-Cell Destruction in NOD Mice Given Cyclophosphamide , 1988, Diabetes.

[8]  K. Amano,et al.  Evidence for Initial Involvement of Macrophage in Development of Insulitis in NOD Mice , 1988, Diabetes.

[9]  G. Morahan,et al.  Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells , 1988, Nature.

[10]  C. Fathman,et al.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. , 1988, Science.

[11]  L. Wicker,et al.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.

[12]  H. Rosen,et al.  Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo , 1987, The Journal of experimental medicine.

[13]  K. Lafferty,et al.  Combined Treatment With Nicotinamide and Desferrioxamine Prevents Islet Allograft Destruction in NOD Mice , 1986, Diabetes.

[14]  H. Waldmann,et al.  Tolerance to rat monoclonal antibodies. Implications for serotherapy , 1986, The Journal of experimental medicine.

[15]  S. Gordon,et al.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage , 1981, European journal of immunology.

[16]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.